Aurinia Pharmaceuticals Inc. (AUPH) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$283.1M

Net Income/Loss (FY2025)

$287.2M

Total Assets (FY2025)

$751.6M

Total Equity (FY2025)

$581.3M

Cash Flows from Operating Activities (FY2025)

$135.7M

Source: Aurinia Pharmaceuticals Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.